ArticleOncology letters2019

Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.

Gangyue Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.